Eton Pharmaceuticals, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 530.2K | $13.09M | 0.00% | Added+5.6% | 2026-03-31 |
| RenTech | quant | 163.3K | $4.03M | 0.01% | Trimmed-20.6% | 2026-03-31 |
| TwoSigma | quant | 106.4K | $2.63M | 0.00% | Added+38.9% | 2026-03-31 |
| Wellington | fundamental | 70.1K | $1.73M | 0.00% | Trimmed-13.6% | 2026-03-31 |
| FidelityFMR | fundamental | 1.5K | $37.48K | 0.00% | Trimmed-50.6% | 2026-03-31 |
| TRowePrice | fundamental | 17.7K | $436 | 0.00% | Added+14.9% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-06upcoming | 0.19 | — | — |
| 2026-05-14 | 0.09 | 0.05 | -44.44% |
| 2026-03-19 | 0.20 | 0.19 | -5.00% |
| 2025-11-06 | 0.16 | 0.04 | -75.00% |
| 2025-08-07 | 0.02 | 0.03 | +28.59% |
| 2025-05-13 | 0.05 | -0.06 | -212.51% |
| 2025-03-18 | — | -0.03 | -800.90% |
| 2024-11-12 | -0.01 | 0.02 | +300.00% |
| 2024-08-08 | -0.07 | -0.12 | -71.43% |
| 2024-05-09 | -0.07 | -0.03 | +57.14% |
| 2024-03-14 | -0.04 | -0.09 | -125.00% |
| 2023-11-09 | -0.10 | -0.02 | +80.00% |
| 2023-08-10 | -0.09 | 0.18 | +300.00% |
| 2023-05-11 | -0.14 | -0.10 | +28.57% |
| 2023-03-16 | 0.01 | 0.04 | +300.00% |
| 2022-11-10 | -0.15 | -0.12 | +20.00% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| ETON | +5.36% | +74.50% | +80.07% | +61.20% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +2.39% | +79.14% | +83.51% | +48.51% |